Stock listing

NSB Stock Price, News, Filings & Events — Neuroscientific Biopharmaceuticals Ltd.

Selected listing: NSB · ASX · AUD · AU

This page tracks Neuroscientific Biopharmaceuticals Ltd.'s NSB:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NSB:ASX. NSB:ASX is the stock-level entry point for investors researching Neuroscientific Biopharmaceuticals Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Neuroscientific Biopharmaceuticals Ltd. (ticker: NSB) is a public company listed on the Australian market, with a market capitalization of approximately AUD 17.72 million. The company focuses on developing innovative biopharmaceutical products aimed at addressing neurological disorders. Its commitment to research and development positions it within the growing biopharmaceutical sector.

NSB:ASXAUDAUUpdated August 21, 2026
Neuroscientific Biopharmaceuticals Ltd. logo
Ticker
NSB:ASX
Asset type
Stock
Market cap
$18.3M
Sector
Health Technology
Industry
Biotechnology
Exchange
ASX
Currency
AUD

Neuroscientific Biopharmaceuticals Ltd. NSB:ASX stock context

This page tracks Neuroscientific Biopharmaceuticals Ltd.'s NSB:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NSB:ASX. NSB:ASX is the stock-level entry point for investors researching Neuroscientific Biopharmaceuticals Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Neuroscientific Biopharmaceuticals Ltd. (ticker: NSB) is a public company listed on the Australian market, with a market capitalization of approximately AUD 17.72 million. The company focuses on developing innovative biopharmaceutical products aimed at addressing neurological disorders. Its commitment to research and development positions it within the growing biopharmaceutical sector.

Latest news from Neuroscientific Biopharmaceuticals Ltd.

All Neuroscientific Biopharmaceuticals Ltd. news →

Research Neuroscientific Biopharmaceuticals Ltd.